Ruzieh Mohammed, Ghahramani Mehrdad, Nudy Matthew, Naccarelli Gerald V, Mandrola John, Grubb Blair P, Foy Andrew J
Penn State Heart and Vascular Institute, 500 University Drive, PO Box 850, MC H047, Hershey, PA, 17033, USA.
Penn State Department of Internal Medicine, Hershey, USA.
J Interv Card Electrophysiol. 2019 Jun;55(1):105-113. doi: 10.1007/s10840-019-00531-0. Epub 2019 Mar 12.
A proportion of patients with vasovagal syncope (VVS) experience recurrence despite appropriate management. Closed loop stimulation (CLS) pacing is a promising treatment for a subgroup of patients with cardioinhibitory response on head-up tilt table test (HUTT). Nonetheless, its efficacy remains uncertain. We sought to assess the efficacy of CLS pacing in patients with cardioinhibitory VVS.
We searched PubMed, Google Scholar, and the Cochrane Central Register of controlled trials for relevant studies (last search date April 23, 2018). Data were pooled using the Mantel-Haenszel fixed-effects model. For cohort studies, we used a Freeman-Tukey transformation to calculate the weighted summary proportion. Primary outcomes are syncope and presyncope.
Eight studies were included in the final analyses (two single-blinded and one double-blinded RCT, two prospective observational studies, and three retrospective observational studies). Two hundred ninety-one patients included, with an average age of 57 years. Quality of evidence is moderate. Use of CLS pacing was associated with reduced risk of syncope (OR 0.08; 95% CI 0.03-0.18; I 32%) and presyncope (OR 0.34; 95% CI 0.18-0.63; I 0.00%). Using proportion meta-analysis, the summary estimate of the proportion of cases that developed syncope during CLS pacing was similar between RCTs and prospective studies (3.2% and 3.1%), respectively. This is much lower than the rate of recurrence in the control arm of RCTs at 33.7%. Sensitivity analyses yielded similar results.
CLS pacing is beneficial for patients with recurrent vasovagal syncope who demonstrate a cardioinhibitory response on HUTT.
尽管进行了适当的管理,仍有一部分血管迷走性晕厥(VVS)患者会复发。闭环刺激(CLS)起搏对于在头直立倾斜试验(HUTT)中出现心脏抑制反应的亚组患者是一种有前景的治疗方法。然而,其疗效仍不确定。我们旨在评估CLS起搏对心脏抑制性VVS患者的疗效。
我们在PubMed、谷歌学术和Cochrane对照试验中央登记库中搜索相关研究(最后搜索日期为2018年4月23日)。使用Mantel-Haenszel固定效应模型汇总数据。对于队列研究,我们使用Freeman-Tukey变换来计算加权汇总比例。主要结局是晕厥和晕厥前状态。
八项研究纳入最终分析(两项单盲和一项双盲随机对照试验、两项前瞻性观察性研究和三项回顾性观察性研究)。共纳入291例患者,平均年龄5岁。证据质量为中等。使用CLS起搏与晕厥风险降低相关(比值比0.08;95%置信区间0.03 - 0.18;I² 32%)和晕厥前状态风险降低相关(比值比0.34;95%置信区间0.18 - 0.63;I² = 0.00%)。使用比例荟萃分析,随机对照试验和前瞻性研究中CLS起搏期间发生晕厥的病例比例的汇总估计值分别相似(3.2%和3.1%)。这远低于随机对照试验对照组33.7%的复发率。敏感性分析得出类似结果。
CLS起搏对在HUTT中表现出心脏抑制反应的复发性血管迷走性晕厥患者有益。